Development of Traceable Rituximab-Modified PEO-Polyester Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell Lymphoma

[Image: see text] The objective of this work was to develop rituximab (RTX)-modified polymeric micelles for targeting of B-cell lymphoma cells, through postinsertion of RTX-poly(ethylene glycol)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (RTX-PEG-DSPE) into methoxy poly(ethylene oxide)-poly(ε-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Saqr, Asma, Vakili, Mohammad Reza, Huang, Yung-Hsing, Lai, Raymond, Lavasanifar, Afsaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854837/
https://www.ncbi.nlm.nih.gov/pubmed/31737848
http://dx.doi.org/10.1021/acsomega.9b02910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854837/
https://www.ncbi.nlm.nih.gov/pubmed/31737848
http://dx.doi.org/10.1021/acsomega.9b02910

Ejemplares similares